Scientists from the universities of Granada (UGR) and Valencia (UV) have developed a new molecular method for determining the presence of the parasite Toxoplasma gondii, which causes toxoplasmosis, in samples of ham.
Image of a Toxoplasma parasite under electron microscope. A and B are infecting forms isolated from tissues under scanning electron microscopy. C corresponds to infectious tissue forms observed by transmission electron microscopy, and D shows the development within a cell cultured in vitro. Courtesy of Luis M. De Pablos Torró - Biotechnology Institute
Scientists from the universities of Granada (UGR) and Valencia (UV) have developed a new molecular method for determining the presence of the parasite Toxoplasma gondii, which causes toxoplasmosis, in samples of ham.
Said new method, published in two articles in the scientific journal Food Microbiology, consists in the capture of the parasite's DNA by magnetic particles functionalized with specific sequences of the parasite, and the quantification of said DNA using a quantitative PCR (qPCR) technique .
The method has a sensitivity capable of detecting a parasite cell in 100 grams of the ham sample with an efficiency of 94.6 percent. Similarly, scientists have determined the infectivity of the parasites detected in the samples.
The authors of this research are Antonio Osuna, Mercedes Gómez-Samblás and Susana Vílchez, belonging to the research team CTS-183 Biochemistry and Molecular Parasitology at the University of Granada and the Institute of Biotechnology, along with researcher Marius Fuentes from the University of Valencia.
In order to carry out this work, they analyzed 475 commercial samples of ham presented in two formats, slices and cubes, and estimated the number of T. gondii parasites present in them. This is the first study of its kind to be performed.
The results showed that the prevalence of T. gondii in ham samples varied from 0 percent to 32.35 percent, depending on the production company, and that 4.84 percent of the positive samples were infective in mice, that is, they caused an infection to the animals.
Moreover, the prevalence of T. gondii in commercial ham samples was 8.84 percent with a viability rate of 4.84 percent. Some of the samples presented high levels of both positive cases and infectivity, although some of them were negative either by the absence of the parasite or because the parasites were not infectious. Prevalence and viability rates were assessed based on the presentation of the product (vacuum-sealed cubes or slices). No significant differences were observed between their rates.
Statistical analysis of the prevalence results obtained by the researchers showed that there are significant differences between samples of different brands. Thus, the prevalence and viability of the parasite in ham samples depends on the production company and the origin of the animals, which implies variations or noncompliance with regulations during the curing process.
As UGR professor Antonio Osuna, lead author of this work, explains, "despite health controls, the pig still remains a potentially important source of the parasite T. gondii, one of the worst opportunistic parasites in immunosuppressed people, responsible for malformation and deficiencies in newborns, such us microcephaly, hydrocephaly, blindness, and congenital heart diseases, if the primary infection occurs in pregnant mothers".
The researchers have proven that if ham meat samples are frozen before the curing process the elimination of the parasite is much faster. They have also determined that the treatment normally used for curing ham using nitrites along with sea salt increases Toxoplasma's survival time and therefore, the infectivity rate, when compared to curing carried out using only sea salt.
In light of the results of this study, the researchers suggest that the traditional salting method for the production of ham ensures the total elimination of T. gondii, provided that the curing period that marks the current legislation is respected.
Moreover, the use of nitrite during the salting process performed to control microorganisms originated in the ham retards the inactivation process of T. gondii, possibly due to a delay in the lipolysis phenomenon, which makes necessary higher curing periods (at least 7 months) to ensure complete elimination of the parasite.
"Ham industry producers can ensure complete removal of T. gondii by freezing the pieces of meat, be it before the salting process or after the curing period", says professor Osuna. The freezing process is not covered by ham production regulations because they alter the organoleptic properties of some processed products in which the buquet, texture and aroma are highly appreciated.
The application of this study could be an advantage for companies producing ham and pig shoulders, given that they could give their products an added value by ensuring that they are T. gondii free and thus ensuring the safety of their products.
Source: University of Granada
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.